Better Buy: Abbott Laboratories vs. DexCom [The Motley Fool]
DexCom, Inc. (DXCM)
Last dexcom, inc. earnings: 4/28 04:03 pm
Check Earnings Report
US:NASDAQ Investor Relations:
dexcom.com/investors
Company Research
Source: The Motley Fool
Medical device makersAbbott Laboratories(NYSE:ABTDexComNASDAQ:DXCMThere are million diabetics in the United States, with . million people newly diagnosed each year. Many diabetics are turning to CGMs -- which provide real-time monitoring, rather than requiring a finger prick -- to ensure their blood sugar is at a healthy level. Companies that sell CGMs can expect both growth and competition in the space; the compound annual growth rate is expected to be roughly % through 07, according to one study.Image source: Getty Images.The case for DexComDexCom stock is up more than 6% this year,but in the past three monthsThere are several explanations for the stock's recent decline. For one, it's facing increased competitive pressure in the CGM space from Abbott, which recently launched its Freestyle Libre device in Europe and will do so in the U.S. soon.DexCom's current GCM model, the G6, uses sensors that must be replaced every 0 days, with a cost that can run to $,88 per year before insuran
Show less
Read more
Impact Snapshot
Event Time:
DXCM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DXCM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DXCM alerts
High impacting DexCom, Inc. news events
Weekly update
A roundup of the hottest topics
DXCM
News
- DexCom (DXCM) to Report Q1 Earnings: What's in the Cards? [Yahoo! Finance]Yahoo! Finance
- Epitel Receives FDA 510(k) Clearance for Two New Technologies: REMI Remote EEG Monitoring System for Ambulatory Use and REMI Vigilenz AI For Event Detection [Yahoo! Finance]Yahoo! Finance
- Ahead of DexCom (DXCM) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics [Yahoo! Finance]Yahoo! Finance
- DexCom Insiders Sold US$18m Of Shares Suggesting Hesitancy [Yahoo! Finance]Yahoo! Finance
- IDTechEx Examines the Opportunities for Wearables in Digital Health [Yahoo! Finance]Yahoo! Finance
DXCM
Earnings
- 2/8/24 - Beat
DXCM
Sec Filings
- 4/23/24 - Form 144
- 4/22/24 - Form ARS
- 4/22/24 - Form DEF
- DXCM's page on the SEC website